Xue ZM - Search Results

1

Clinical Features and Outcomes of Long-Term Lead Performance by Left Bundle Branch Pacing.

Pan YW, Zhou X, Yu C, Sheng X, Ma ZH, Xue ZM, Xu TT, Gao J, Zhang JF. Pan YW, et al. Among authors: xue zm. Int Heart J. 2024;65(5):800-807. doi: 10.1536/ihj.24-038. Int Heart J. 2024. PMID: 39343585 Free article.

2

Protective effect and mechanism of procyanidin B2 against hypoxic injury of cardiomyocytes.

Xue Z, Wu D, Zhang J, Pan Y, Kan R, Gao J, Zhou B. Xue Z, et al. Heliyon. 2023 Oct 20;9(11):e21309. doi: 10.1016/j.heliyon.2023.e21309. eCollection 2023 Nov. Heliyon. 2023. PMID: 37885736 Free PMC article.

3

Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion.

Xue Z, Pan Y, Kong X, Zhang J, Wu D, Zhou B. Xue Z, et al. J Cell Mol Med. 2023 Jan;27(1):89-100. doi: 10.1111/jcmm.17637. Epub 2022 Dec 10. J Cell Mol Med. 2023. PMID: 36495058 Free PMC article.

4

[Safety and efficacy of transradial percutaneous coronary intervention for unprotected left main coronary artery lesions with 6 French guiding catheter].

He M, Xue ZM, Zhou BQ, Fu GS. He M, et al. Among authors: xue zm. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Nov;41(6):672-6. doi: 10.3785/j.issn.1008-9292.2012.06.011. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23239660 Chinese.

5

The Effect of Different Statin-Based Lipid-Lowering Strategies on C-Reactive Protein Levels in Patients With Stable Coronary Artery Disease.

Xue Z, Ye M, Jiang H, Li D, Hong X, Chen Z, Li Y, Zhou B, Zhang W, Wang M. Xue Z, et al. Clin Cardiol. 2024 Jun;47(6):e24301. doi: 10.1002/clc.24301. Clin Cardiol. 2024. PMID: 38895772 Free PMC article.

6

Proline improves cardiac remodeling following myocardial infarction and attenuates cardiomyocyte apoptosis via redox regulation.

Wang J, Xue Z, Lin J, Wang Y, Ying H, Lv Q, Hua C, Wang M, Chen S, Zhou B. Wang J, et al. Biochem Pharmacol. 2020 Aug;178:114065. doi: 10.1016/j.bcp.2020.114065. Epub 2020 May 31. Biochem Pharmacol. 2020. PMID: 32492448 Free article.

7

Metabolomic Analysis of the Ameliorative Effect of Enhanced Proline Metabolism on Hypoxia-Induced Injury in Cardiomyocytes.

Wang J, Xue Z, Hua C, Lin J, Shen Z, Song Y, Ying H, Lv Q, Wang M, Zhou B. Wang J, et al. Oxid Med Cell Longev. 2020 Nov 26;2020:8866946. doi: 10.1155/2020/8866946. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33294127 Free PMC article.

8

Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway.

He M, Xue ZM, Li J, Zhou BQ. He M, et al. Among authors: xue zm. Acta Pharmacol Sin. 2012 May;33(5):606-14. doi: 10.1038/aps.2012.6. Epub 2012 Apr 2. Acta Pharmacol Sin. 2012. PMID: 22465949 Free PMC article.

9

Regulable high-contrast mechanofluorochromic enhancement behaviour based on substituent effects.

Yang G, Zhao WX, Cao JY, Xue ZM, Lin HT, Chen SH, Yamato T, Redshaw C, Wang CZ. Yang G, et al. Among authors: xue zm. Chem Commun (Camb). 2024 Apr 4;60(29):3966-3969. doi: 10.1039/d4cc00476k. Chem Commun (Camb). 2024. PMID: 38501379

10

Comparison of His-Purkinje Conduction System Pacing with Atrial-Ventricular Node Ablation and Pharmacotherapy in HFpEF Patients with Recurrent Persistent Atrial Fibrillation (HPP-AF study).

Zhang JF, Pan YW, Li J, Kong XG, Wang M, Xue ZM, Gao J, Fu GS. Zhang JF, et al. Among authors: xue zm. Cardiovasc Drugs Ther. 2024 Aug;38(4):847-858. doi: 10.1007/s10557-023-07435-2. Epub 2023 Feb 7. Cardiovasc Drugs Ther. 2024. PMID: 36749453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters